Quality control of ranitidine hydrochloride compounded capsules
The class of medicines most used for the treatment of gastric disorders is histamine H2 receptor inhibitors, reducing the gastric acid secretion. Ranitidine hydrochloride is one of the most used agents of this class, usually found as 150 and 300 mg tablets. Dispensing extemporaneous compounds has be...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidade Federal de Rondonópolis
2018-10-01
|
| Series: | Scientific Electronic Archives |
| Subjects: | |
| Online Access: | http://www.seasinop.com.br/revista/index.php?journal=SEA&page=article&op=view&path%5B%5D=697&path%5B%5D=pdf |
| _version_ | 1818151064714608640 |
|---|---|
| author | T. F. F. Silva M. P. R. Torres M. P. Ribeiro A. L. Raiser E. B. Ribeiro C. R. Andrighetti M. Z. Marques L. G. Vasconcelos D. M. S. Valladão |
| author_facet | T. F. F. Silva M. P. R. Torres M. P. Ribeiro A. L. Raiser E. B. Ribeiro C. R. Andrighetti M. Z. Marques L. G. Vasconcelos D. M. S. Valladão |
| author_sort | T. F. F. Silva |
| collection | DOAJ |
| description | The class of medicines most used for the treatment of gastric disorders is histamine H2 receptor inhibitors, reducing the gastric acid secretion. Ranitidine hydrochloride is one of the most used agents of this class, usually found as 150 and 300 mg tablets. Dispensing extemporaneous compounds has been shown as alternative when patient seeks for medicines with personalized doses or lower cost, resulting in a progressive increase of this type of medicine. Aiming to evaluate the quality of extemporaneous compounding, this work verified the quality of ranitidine hydrochloride capsules from three compounding pharmacies (F1, F2 and F3) of the state of Mato Grosso. Trials were conducted according to Brazilian Pharmacopeia. Results showed that compounded capsules from F1 and F3 met the Brazilian Pharmacopeia specifications while the F2 ones were out of specification limits. Therefore, it was observed that it is needed a strict control over the compounding process to assure quality, effective and safe products. |
| first_indexed | 2024-12-11T13:32:53Z |
| format | Article |
| id | doaj.art-760d9c2fa0124fdbb447b3553f72ce43 |
| institution | Directory Open Access Journal |
| issn | 2316-9281 2316-9281 |
| language | English |
| last_indexed | 2024-12-11T13:32:53Z |
| publishDate | 2018-10-01 |
| publisher | Universidade Federal de Rondonópolis |
| record_format | Article |
| series | Scientific Electronic Archives |
| spelling | doaj.art-760d9c2fa0124fdbb447b3553f72ce432022-12-22T01:05:11ZengUniversidade Federal de RondonópolisScientific Electronic Archives2316-92812316-92812018-10-01115154161Quality control of ranitidine hydrochloride compounded capsulesT. F. F. SilvaM. P. R. TorresM. P. RibeiroA. L. RaiserE. B. RibeiroC. R. AndrighettiM. Z. MarquesL. G. VasconcelosD. M. S. ValladãoThe class of medicines most used for the treatment of gastric disorders is histamine H2 receptor inhibitors, reducing the gastric acid secretion. Ranitidine hydrochloride is one of the most used agents of this class, usually found as 150 and 300 mg tablets. Dispensing extemporaneous compounds has been shown as alternative when patient seeks for medicines with personalized doses or lower cost, resulting in a progressive increase of this type of medicine. Aiming to evaluate the quality of extemporaneous compounding, this work verified the quality of ranitidine hydrochloride capsules from three compounding pharmacies (F1, F2 and F3) of the state of Mato Grosso. Trials were conducted according to Brazilian Pharmacopeia. Results showed that compounded capsules from F1 and F3 met the Brazilian Pharmacopeia specifications while the F2 ones were out of specification limits. Therefore, it was observed that it is needed a strict control over the compounding process to assure quality, effective and safe products.http://www.seasinop.com.br/revista/index.php?journal=SEA&page=article&op=view&path%5B%5D=697&path%5B%5D=pdfcontrolqualityranitidine hydrochloridecapsule |
| spellingShingle | T. F. F. Silva M. P. R. Torres M. P. Ribeiro A. L. Raiser E. B. Ribeiro C. R. Andrighetti M. Z. Marques L. G. Vasconcelos D. M. S. Valladão Quality control of ranitidine hydrochloride compounded capsules Scientific Electronic Archives control quality ranitidine hydrochloride capsule |
| title | Quality control of ranitidine hydrochloride compounded capsules |
| title_full | Quality control of ranitidine hydrochloride compounded capsules |
| title_fullStr | Quality control of ranitidine hydrochloride compounded capsules |
| title_full_unstemmed | Quality control of ranitidine hydrochloride compounded capsules |
| title_short | Quality control of ranitidine hydrochloride compounded capsules |
| title_sort | quality control of ranitidine hydrochloride compounded capsules |
| topic | control quality ranitidine hydrochloride capsule |
| url | http://www.seasinop.com.br/revista/index.php?journal=SEA&page=article&op=view&path%5B%5D=697&path%5B%5D=pdf |
| work_keys_str_mv | AT tffsilva qualitycontrolofranitidinehydrochloridecompoundedcapsules AT mprtorres qualitycontrolofranitidinehydrochloridecompoundedcapsules AT mpribeiro qualitycontrolofranitidinehydrochloridecompoundedcapsules AT alraiser qualitycontrolofranitidinehydrochloridecompoundedcapsules AT ebribeiro qualitycontrolofranitidinehydrochloridecompoundedcapsules AT crandrighetti qualitycontrolofranitidinehydrochloridecompoundedcapsules AT mzmarques qualitycontrolofranitidinehydrochloridecompoundedcapsules AT lgvasconcelos qualitycontrolofranitidinehydrochloridecompoundedcapsules AT dmsvalladao qualitycontrolofranitidinehydrochloridecompoundedcapsules |